Bradford Hill and breast implant illness: no evidence for causal association with breast implants

Click to increase image sizeClick to decrease image size

Acknowledgments

The Dutch Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Research-Consortium includes Mintsje de Boer, MD, PhD, Department of plastic and reconstructive surgery, Maastricht University Medical Centre, Daphne de Jong, MD, PhD, Professor of Haematopathology, Cancer Centre Amsterdam, Amsterdam, Hinne Rakhorst, MD, PhD, Department of Plastic and reconstructive surgery, Medisch Spectrum Twente, Enschede, Flora E. van Leeuwen, PhD, Professor of Epidemiology of Cancer, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, Marc A.M. Mureau, MD, PhD, Professor of Oncological Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, René R.W.J. van der Hulst, MD, PhD, Professor of Plastic and Reconstructive Surgery, Maastricht University Medical Center, Maastricht, Jan Paul de Boer, MD, PhD, Department of Medical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, and Jonathan Spoor, MD, Department of Epidemiology, Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam, The Netherlands

Disclosure statement

No potential conflict of interest was reported by the author(s).

Editor disclosures

One of the senior editors for this journal has served as a medical expert for the United States government, in the US vaccine court, in defence against autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA). He thus recused himself and held no decision-making powers on this or related articles. The decision-making editor for this manuscript has no relevant financial relationships or otherwise to disclose.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.